Table 3.
Summary of the purported effects of polyphenols in models of toxicity related to amyloid peptides.
Polyphenols | Study Model | Treatment Duration | Study Outcomes | Refs. |
---|---|---|---|---|
Curcumin | Aged APPsw Tg2576 mice | 5 months | Reduced Aβ levels and plaque burden | [27] |
Parts of Tg2576 mouse brain | 3-6 days | Suppressed Aβ aggregation; mediated disaggregation of Aβ | ||
Neuronal hippocampal cultures | 1 to 24 hours | Suppressed the generation of Aβ fibrils and fibril-destabilizing activities |
||
Resveratrol | Neuronal hippocampal cultures | 2 hours | Blocked Aβ-induced toxicity | [30, 245, 246] |
Cells transfected with human APP695 | 24 hours | Mediated Aβ degradation | ||
Neuronal hippocampal cultures | 24 hours | Showed anti-amyloidogenic properties | ||
Myricetin | Neuronal hippocampal cultures | 1 to 24 hours | Showed fibril-destabilizing properties; blocked Aβ(1-40)-induced toxicity; suppressed the generation of Aβ fibrils | [25] |
EGCG | Neuronal hippocampal cultures | 24-48 hours | Suppressed soluble forms of Aβ and Aβ fibrilization; blocked Aβ(1-42)-induced toxicity | [219, 263, 264] |
Tg APPsw mouse models | 2 months | Reduced Aβ levels and Aβ plaques | ||
C57/BL mouse models; human neuroblastoma cells | 7-14 days | Elevated the levels of sAPP release; mediated non-amyloidogenic pathway |
||
Ellagic acid and Punicalagin | Tg APPsw/Tg2576 mouse models | 6-8 months | Ameliorated AD-like pathology and behavior along with a reduced level of Aβ(1-42) and Aβ deposition | [172] |
Gallic acid and tannic acid |
Neuronal hippocampal cultures | 1 to 24 hours | Showed fibril-destabilizing properties; blocked Aβ-induced toxicity; suppressed the generation of Aβ fibrils | [265] |